Innoviva (NASDAQ: INVA) reported Q1 EPS of $0.51, $0.28 better than the analyst estimate of $0.23. Revenue for the quarter came in at $76.37 million versus the consensus estimate of $61.46 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.